Cardiometabolic Health Congress

JULY 25, 2024

The conference will equip health professionals with clinical strategies that promote comprehensive health and tools to harness new therapies to improve our collective health outcomes. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 100

Education Innovation Risk Factors Obesity 100

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundAortic stenosis has pathophysiological similarities with atherosclerosis, including the deposition of cholesterol‐containing lipoproteins. Journal of the American Heart Association, Ahead of Print. In multivariate analysis, low CCDR (hazard ratio, 2.21 [95% CI, 0.99–4.92],P=0.04)

Aortic valve 40

Aortic valve Cholesterol Aortic Stenosis 40

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Ballantyne, MD , explored Lipoprotein(a).

CME 64

CME Innovation Education Atherosclerosis 64

Stroke: Vascular and Interventional Neurology

JUNE 20, 2024

While traditional vascular risk factors (eg, hypertension, dyslipidemia, tobacco use) account for 20% of the explained variance in carotid atherosclerosis, they remain a prominent focus for primary and secondary ischemic stroke prevention strategies. Stroke: Vascular and Interventional Neurology, Ahead of Print.

Cerebrovascular Disease 40

Cerebrovascular Disease Atherosclerosis Atrial Fibrillation Physiology 40

Circulation

NOVEMBER 11, 2024

Inflammatory indicators such as neutrophil count and monocyte count potentially may predict patients’ outcomes and prognosis in ACS. Rate of MACE as composite outcome 30-days after PPCI as 24.7% (n=37). White blood cells count is an affordable and accessible way to assess the systemic immune response.

Angina 40

Angina Coronary Artery Disease Biomarkers Atherosclerosis 40

Journal of Cardiovascular Pharmacology

SEPTEMBER 4, 2023

Dysregulation of the innate and adaptive immune system is accelerated by CKD and results in increased systemic inflammation, a heightened local vascular inflammatory response leading to accelerated atherosclerosis, and dysfunction of the cardiac and renal endothelium and microcirculation.

Kidney Disease 40

Kidney Disease Transplant Atherosclerosis Biomarkers 40

Dr. Paddy Barrett

OCTOBER 31, 2023

They have the biomarker of risk but no evidence of the disease , even later in life when you would expect them to have it. When there is a history of early events, then the likelihood of a member of that family with an elevated Lp(a) having premature coronary atherosclerosis is high. Atherosclerosis. 2017 Jan;256:47-52.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

Dr. Smith's ECG Blog

JANUARY 3, 2022

4] CT revealed no dissection but extensive coronary atherosclerosis. So even without the diagnostic ECGs, they had clinical evidence of refractory ischemia with biomarker (troponin) confirmation. In a study last year, 14.4% of patients diagnosed with STEMI had an initial troponin less than the 99 th percentile, including 23.4%

STEMI 52

STEMI Myocardial Infarction Chest Pain Ischemia 52

DAIC

DECEMBER 13, 2023

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE. THE UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE'S CLINT L.

Heart Attack 105

Heart Attack Heart attacks Atherosclerosis Plaque 105

DAIC

JANUARY 23, 2024

5 Over my career as a cardiovascular surgeon, as well as an immunologist, I have witnessed how current treatments for ASCVD have led to considerable improvements in outcomes, yet many patients remain vulnerable to life-threatening cardiac events.1,6

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Cardiometabolic Health Congress

AUGUST 8, 2024

This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life. Key contributions: Advanced cardiac imaging (e.g.,

Education 59

Education Cardiovascular Disease Kidney Disease Diabetes 59

Stroke Journal

JANUARY 30, 2025

Background and Purpose:Chronic kidney disease (CKD) is associated with an increased risk of stroke and worse outcomes, yet it is often asymptomatic, with an estimated 90% of individuals unaware they have CKD until its later stages. Stroke, Volume 56, Issue Suppl_1 , Page A102-A102, February 1, 2025.

Atherosclerosis 40

Atherosclerosis Kidney Disease Blood Pressure Biomarkers 40

All About Cardiovascular System and Disorders

DECEMBER 15, 2023

Though this effect has also been documented with statin therapy, monotherapy using PCSK9 inhibitors or ezetimibe have not been associated with similar reduction in biomarkers of inflammation. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. at 6 months compared to placebo. N Engl J Med. Epub 2023 Mar 4.

Cholesterol 52

Cholesterol Myocardial Infarction Cardiovascular Disease Diabetes 52

Physiologically Speaking

DECEMBER 17, 2024

Coronary artery calcium (CAC) is a measure of atherosclerosis and a strong predictor of cardiovascular disease. The Latest Evidence on Atherosclerosis in Athletes The risk factor component is yet unexplored—how do risk factors other than training contribute to elevated CAC in endurance athletes?

Risk Factors 105

Risk Factors Genetic predisposition Plaque Exercise 105

Cardiometabolic Health Congress

NOVEMBER 14, 2024

With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. cardiometabolic health CME/CE conference: the 19th Annual CMHC.

CME 103

CME Obesity Heart Failure Biomarkers 103